Pyrogen Testing Market 2022-2028

Description

List of Tables

Global Pyrogen Testing Market Size, Share & Trends Analysis Report by Product &Services (Assays, Kits & Reagents, Instruments, and Services), By Test Type (LAL, Monocyte Activation Chromogenic, Turbidimetric, Gel Clot, In Vitro, Rabbit, and Others), By End-User (Pharmaceutical companies, Biotechnology Companies, Medical Device Companies and, Others), Forecast Period (2022-2028)

The global Pyrogen Testing market is anticipated to grow at a substantial CAGR of around 8.5% during the forecast period. Rising need for biologics that have resulted in unexpected growth in the number of biopharmaceutical companies and increasing significant investment in R&D of new pyrogen testing kits are the key factors boosting the market growth. All this rising need for biologics in turn is helping to develop therapeutically advanced drugs on a large scale, that are compelling manufacturers to improve on aspects, such as productivity, cost-efficiency, and deviations. Moreover, Various key players and other companies are implementing good manufacturing practices through biological testing in their production cycles to fulfil the growing market demands For instance, in July 2020, for the commercialization of a range of specialized reagents for pyrogen testing of parenteral pharmaceuticals and medical devices, Lonza and Sanquin Reagents came into a strategic partnership.

The global pyrogen testing Market is segmented based on the product & services, test type, and end-user. On the basis of product and services, the market is segmented into assays, kits & reagents, instruments, and services. Based on the test type the market is sub-divided into LAL, monocyte activation, chromogenic, turbidimetric, gel clot, vitro, rabbit, and others. On the basis of end-user, the market is sub-segmented into pharmaceutical companies, biotechnology companies, medical device companies, and others. Among the product and services segment, the kits & reagents segment is dominating owing to the preference for kit-based testing and the frequent requirement of kits, and reagents in large numbers.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is dominating in the pyrogen testing market attributed to the better regulatory framework, increasing prevalence of chronic and infectious diseases. The rising demand for a growing number of drugs approvals is driving the growth of the pyrogen testing market in the region. For instance, in July 2021, OncoMate MSI Dx Analysis System (OncoMate MSI) that is developed by Promega, has cleared by the US Food and Drug Administration (FDA) as an IVD medical device to determine microsatellite instability (MSI) status in colorectal cancer tumors. Moreover, the PCR-based diagnostic kit for MSI characterization has been FDA-cleared for use in labs across the US. Moreover, presence of many large biotechnological and biopharmaceutical firms, such as Merck and Lonza Group, among others.

The major companies serving the global Pyrogen Testing market BIOMERIEUX SA, Charles River Laboratories International, Inc., Ellab A/S, GenScript Biotech Corp., Lonza Group Ltd., MAT BioTech B.V., Merck KGaA, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, In October 2020, Lonza Bioscience launched PyroCell MAT System, a sustainable and reliable solution for in vitro pyrogen testing. The new offering will expand upon Lonza's experience in primary cells and endotoxin testing, that is combined with Sanquin's expertise in MAT production, and will help in ensuring the safety of parenteral pharmaceuticals during development, manufacture, and product release.

Research Methodology

The market study of the global Pyrogen Testing market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

Financial reports of companies involved in the market.
Whitepapers, research papers, and news blogs.
Company websites and their product catalog.

The report provides an in-depth analysis of the market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Pyrogen Testing Market Research and Analysis by Product & Service

2. Global Pyrogen Testing Market Research and Analysis by Test Type

3. Global Pyrogen Testing Market Research and Analysis by End-User

The Report Covers:

Comprehensive Research Methodology of the global Pyrogen Testing market.
This report also includes a detailed and extensive market overview with key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global Pyrogen Testing market.
Insights about market determinants that are stimulating the global Pyrogen Testing market.
Detailed and extensive market segments with the regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

Product Code: OMR2026359

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
Impact of COVID-19 on the Global Pyrogen Testing Market
Recovery Scenario of Global Pyrogen Testing Market
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. BY Region

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. BIOMERIEUX SA
- 3.1.1. Overview
- 3.1.2. Financial Analysis
- 3.1.3. SWOT Analysis
- 3.1.4. Recent Developments
3.2. Ellab A/S
- 3.2.1. Overview
- 3.2.2. Financial Analysis
- 3.2.3. SWOT Analysis
- 3.2.4. Recent Developments
3.3. GenScript Biotech Corp.
- 3.3.1. Overview
- 3.3.2. Financial Analysis
- 3.3.3. SWOT Analysis
- 3.3.4. Recent Developments
3.4. Lonza Group Ltd.
- 3.4.1. Overview
- 3.4.2. Financial Analysis
- 3.4.3. SWOT Analysis
- 3.4.4. Recent Developments
3.5. Merck KGaA
- 3.5.1. Overview
- 3.5.2. Financial Analysis
- 3.5.3. SWOT Analysis
- 3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players

4. Market Segmentation

4.1. Global Pyrogen Testing Market by Product & Service
- 4.1.1. Assays
- 4.1.2. Kits & Reagents
- 4.1.3. Instruments
- 4.1.4. Services
4.2. Global Pyrogen Testing Market by Test Type
- 4.2.1. LAL
- 4.2.2. Monocyte Activation
- 4.2.3. Chromogenic
- 4.2.4. Turbidimetric
- 4.2.5. Gel Clot
- 4.2.6. In Vitro
- 4.2.7. Rabbit
- 4.2.8. Others
4.3. Global Pyrogen Testing Market by End-User
- 4.3.1. Pharmaceutical Companies
- 4.3.2. Biotechnology Companies
- 4.3.3. Medical Device Companies
- 4.3.4. Others

5. Regional Analysis

5.1. North America
- 5.1.1. US
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. South Korea
- 5.3.5. Rest of Asia-Pacific
5.4. Rest of the World

6. Company Profiles

6.1. Accugen Laboratories, Inc.
6.2. Almac Group Eurofins Scientific
6.3. Associates Of Cape Cod, Inc.
6.4. Charles River Laboratories International, Inc.
6.5. Eurofins Advinus Ltd.
6.6. Fujifilm Holdings Corp.
6.7. Hycult Biotech Inc.
6.8. INDOOR Biotechnologies, Inc.
6.9. InvivoGen
6.10. Labcorp
6.11. MAT BioTech B.V.
6.12. Microcoat Biotechnologie GmbH
6.13. Minerva Analytix
6.14. Nelson Laboratories, LLC
6.15. Promega Corp
6.16. Sanquin Diagnostics BV
6.17. Solvias AG
6.18. STERIS
6.19. WuXi AppTec
6.20. Xiamen Bioendo Technology Co., Ltd